Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001079973-12-000496)

Filing Details

Accession Number:: 0001079973-12-000496
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-06-29 17:27:00
Reporting Period:: 2012-06-28

Filing Date:: 2012-06-29
Accepted Time:: 2012-06-29 17:27:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1167419	Aspenbio Pharma Inc.	APPY	In Vitro & In Vivo Diagnostic Substances (2835)	841553387

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187604	Jeffrey Mcgonegal	C/O Aspenbio Pharma, Inc. 1585 S. Perry Street Castle Rock CO 80104	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-06-28	5,000	$1.92	13,072	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	500	Indirect	By IRA
Common Stock	50	Indirect	By child

Footnotes

Reflects one-for-six reverse stock split effected on June 20, 2012.